{"id":3625,"date":"2023-12-21T23:58:43","date_gmt":"2023-12-21T23:58:43","guid":{"rendered":"https:\/\/economicherald.net\/?p=3625"},"modified":"2023-12-21T23:58:43","modified_gmt":"2023-12-21T23:58:43","slug":"up-to-1-8m-funding-from-motor-neurone-disease-foundation-could-be-on-the-table-for-pharmaust","status":"publish","type":"post","link":"https:\/\/economicherald.net\/?p=3625","title":{"rendered":"Up to $1.8m funding from motor neurone disease foundation could be on the table for PharmAust"},"content":{"rendered":"

PharmAust invited to apply for up to $1.8m grant funding from FightMND
\nFunding would be applied to company\u2019s Phase 2 study of its drug to treat motor neurone disease and amyotrophic lateral sclerosis
\nSuccessful grant applications will be notified by July 2024<\/p>\n

\u00a0<\/p>\n

Special Report:<\/em> <\/strong>FightMND, Australia\u2019s leading not-for-profit foundation for motor neurone disease research, has invited PharmAust to submit a full grant application to help cover costs of its planned Phase 2 study due to begin in H1 2024.<\/strong><\/p>\n

The company\u2019s planned Phase 2\/3 study is a multicentre, randomised, placebo-controlled, adaptive clinical study evaluating the safety and efficacy of its monepantel (MPL) treatment in patients with Motor Neurone Disease\/Amyotrophic Lateral Sclerosis (MND\/ALS) over 48 weeks.<\/p>\n

The primary aim will be to evaluate the efficacy of MPL, as compared to placebo, on MND\/ALS disease progression.<\/p>\n

Earlier this month, Pharm<\/strong>A<\/strong>ust (ASX:PAA)<\/strong><\/a> submitted a letter of intent to FightMND in response to their call for clinical study proposals aimed at academic-industry partnerships \u2013including but not limited to \u2013 pharmaceutical, bio-therapeutic\/biotechnology companies, academic institutions and universities, hospitals, and MND researchers throughout the world.<\/p>\n

\u00a0<\/strong><\/p>\n

Up to $1.8m could be on the table <\/strong><\/h2>\n

Up to $1.8 million in support from FightMND is available per grant \u2013 and a successful application could play a key role in PAA\u2019s development of the monepantel drug.<\/p>\n

\u201cGaining access to undiluted funds to help offset the costs of drug development is a goal of every biotechnology company,\u201d PAA CEO Dr Michael Thurn said.<\/p>\n

\u201cFightMND has already been influential to date in the development of monepantel for MND\/ALS by fully funding our initial Phase 1 study.<\/p>\n

\u201cBased on the potential shown to date for monepantel to provide patients with MND\/ALS with a treatment benefit, we are excited at our prospects of securing further funding from FightMND for our adaptive Phase 2\/3 study.\u201d<\/p>\n

Applications for grant funding are due by the 24 March 2024, with successful recipients to be notified in July 2024.<\/p>\n

\u00a0<\/p>\n\n

\ufeff<\/span>\u00a0<\/p>\n

This article was developed in collaboration with PharmAust, a Stockhead advertiser at the time of publishing. <\/em><\/p>\n

\u00a0<\/em><\/p>\n

This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.<\/em><\/p>\n

<\/span><\/p>\n

The post Up to $1.8m funding from motor neurone disease foundation could be on the table for PharmAust<\/a> appeared first on Stockhead<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"

PharmAust invited to apply for up to $1.8m grant funding from FightMND Funding would be applied to company\u2019s Phase 2 study of its drug to [more…]<\/a><\/p>\n","protected":false},"author":0,"featured_media":3626,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-3625","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finance"],"yoast_head":"\nUp to $1.8m funding from motor neurone disease foundation could be on the table for PharmAust - Economic Herald<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/economicherald.net\/?p=3625\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Up to $1.8m funding from motor neurone disease foundation could be on the table for PharmAust - Economic Herald\" \/>\n<meta property=\"og:description\" content=\"PharmAust invited to apply for up to $1.8m grant funding from FightMND Funding would be applied to company\u2019s Phase 2 study of its drug to [more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/economicherald.net\/?p=3625\" \/>\n<meta property=\"og:site_name\" content=\"Economic Herald\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-21T23:58:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/12\/PAA-Hero-Pic-1-drx1gC.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2121\" \/>\n\t<meta property=\"og:image:height\" content=\"1193\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=3625#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=3625\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Up to $1.8m funding from motor neurone disease foundation could be on the table for PharmAust\",\"datePublished\":\"2023-12-21T23:58:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=3625\"},\"wordCount\":392,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=3625#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/PAA-Hero-Pic-1-drx1gC.jpeg\",\"articleSection\":[\"Finance\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/economicherald.net\\\/?p=3625#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=3625\",\"url\":\"https:\\\/\\\/economicherald.net\\\/?p=3625\",\"name\":\"Up to $1.8m funding from motor neurone disease foundation could be on the table for PharmAust - Economic Herald\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=3625#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=3625#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/PAA-Hero-Pic-1-drx1gC.jpeg\",\"datePublished\":\"2023-12-21T23:58:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=3625#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/economicherald.net\\\/?p=3625\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=3625#primaryimage\",\"url\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/PAA-Hero-Pic-1-drx1gC.jpeg\",\"contentUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/PAA-Hero-Pic-1-drx1gC.jpeg\",\"width\":2121,\"height\":1193},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=3625#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/economicherald.net\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Up to $1.8m funding from motor neurone disease foundation could be on the table for PharmAust\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/#website\",\"url\":\"https:\\\/\\\/economicherald.net\\\/\",\"name\":\"Economic Herald\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/economicherald.net\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/#organization\",\"name\":\"Economic Herald\",\"url\":\"https:\\\/\\\/economicherald.net\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/cropped-cropped-economicheraldlogo-1.png\",\"contentUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/cropped-cropped-economicheraldlogo-1.png\",\"width\":850,\"height\":760,\"caption\":\"Economic Herald\"},\"image\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Up to $1.8m funding from motor neurone disease foundation could be on the table for PharmAust - Economic Herald","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/economicherald.net\/?p=3625","og_locale":"en_US","og_type":"article","og_title":"Up to $1.8m funding from motor neurone disease foundation could be on the table for PharmAust - Economic Herald","og_description":"PharmAust invited to apply for up to $1.8m grant funding from FightMND Funding would be applied to company\u2019s Phase 2 study of its drug to [more...]","og_url":"https:\/\/economicherald.net\/?p=3625","og_site_name":"Economic Herald","article_published_time":"2023-12-21T23:58:43+00:00","og_image":[{"width":2121,"height":1193,"url":"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/12\/PAA-Hero-Pic-1-drx1gC.jpeg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/economicherald.net\/?p=3625#article","isPartOf":{"@id":"https:\/\/economicherald.net\/?p=3625"},"author":{"name":"","@id":""},"headline":"Up to $1.8m funding from motor neurone disease foundation could be on the table for PharmAust","datePublished":"2023-12-21T23:58:43+00:00","mainEntityOfPage":{"@id":"https:\/\/economicherald.net\/?p=3625"},"wordCount":392,"commentCount":0,"publisher":{"@id":"https:\/\/economicherald.net\/#organization"},"image":{"@id":"https:\/\/economicherald.net\/?p=3625#primaryimage"},"thumbnailUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/12\/PAA-Hero-Pic-1-drx1gC.jpeg","articleSection":["Finance"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/economicherald.net\/?p=3625#respond"]}]},{"@type":"WebPage","@id":"https:\/\/economicherald.net\/?p=3625","url":"https:\/\/economicherald.net\/?p=3625","name":"Up to $1.8m funding from motor neurone disease foundation could be on the table for PharmAust - Economic Herald","isPartOf":{"@id":"https:\/\/economicherald.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/economicherald.net\/?p=3625#primaryimage"},"image":{"@id":"https:\/\/economicherald.net\/?p=3625#primaryimage"},"thumbnailUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/12\/PAA-Hero-Pic-1-drx1gC.jpeg","datePublished":"2023-12-21T23:58:43+00:00","breadcrumb":{"@id":"https:\/\/economicherald.net\/?p=3625#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/economicherald.net\/?p=3625"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/economicherald.net\/?p=3625#primaryimage","url":"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/12\/PAA-Hero-Pic-1-drx1gC.jpeg","contentUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/12\/PAA-Hero-Pic-1-drx1gC.jpeg","width":2121,"height":1193},{"@type":"BreadcrumbList","@id":"https:\/\/economicherald.net\/?p=3625#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/economicherald.net\/"},{"@type":"ListItem","position":2,"name":"Up to $1.8m funding from motor neurone disease foundation could be on the table for PharmAust"}]},{"@type":"WebSite","@id":"https:\/\/economicherald.net\/#website","url":"https:\/\/economicherald.net\/","name":"Economic Herald","description":"","publisher":{"@id":"https:\/\/economicherald.net\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/economicherald.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/economicherald.net\/#organization","name":"Economic Herald","url":"https:\/\/economicherald.net\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/economicherald.net\/#\/schema\/logo\/image\/","url":"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/10\/cropped-cropped-economicheraldlogo-1.png","contentUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/10\/cropped-cropped-economicheraldlogo-1.png","width":850,"height":760,"caption":"Economic Herald"},"image":{"@id":"https:\/\/economicherald.net\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/posts\/3625","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3625"}],"version-history":[{"count":0,"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/posts\/3625\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/media\/3626"}],"wp:attachment":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3625"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3625"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3625"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}